University of Rochester Newsroom

New Long-term Data Demonstrate Patients with Mild Heart Failure Sustained ...
PR Newswire (press release)
NATICK, Mass., March 30, 2014 /PRNewswire/ -- In the longest follow-up to date of cardiac resynchronization therapy (CRT) for mild heart failure patients, Boston Scientific Corporation's (NYSE: BSX) exclusively sponsored and landmark Multicenter ...
Device Saves Lives in Heart Failure PatientsUniversity of Rochester Newsroom
Sheba Medical Center team heads important heart failure researchJerusalem Post
Survival Benefit Found After Long-Term Resynchronization TherapyForbes

all 6 news articles »